Cann Group (ASX:CAN) Receivables Turnover: 6.21 (As of Dec. 2025)


What is Cann Group Receivables Turnover?

Cann Group ASX:CAN Receivables Turnover is 6.21 as of Dec. 2025. The stock has 7 warning signs investors should review. Among 944 Drug Manufacturers companies, Cann Group ranks better than 77.54% on this metric.

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Cann Group's Revenue for the six months ended in Dec. 2025 was A$4.52 Mil. Cann Group's average Accounts Receivable for the six months ended in Dec. 2025 was A$0.73 Mil. Hence, Cann Group's Receivables Turnover for the six months ended in Dec. 2025 was 6.21.


Cann Group  (ASX:CAN) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Cann Group Receivables Turnover Related Terms


Cann Group Receivables Turnover Historical Data

* Premium members only.

The historical data trend for Cann Group's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cann Group Receivables Turnover Chart

Cann Group Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only 2.78 2.49 7.33 9.61 10.30

Cann Group Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.44 2.78 3.44 3.53 6.21

ASX:CAN vs ZTS, UTHR: Receivables Turnover Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cann Group's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cann Group Receivables Turnover vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cann Group's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Cann Group's Receivables Turnover falls into.



Cann Group Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Cann Group's Receivables Turnover for the fiscal year that ended in Jun. 2025 is calculated as

Receivables Turnover (A: Jun. 2025 )
=Revenue / Average Accounts Receivable
=Revenue (A: Jun. 2025 ) / ((Accounts Receivable (A: Jun. 2024 ) + Accounts Receivable (A: Jun. 2025 )) / count )
=11.3 / ((1.607 + 0.587) / 2 )
=11.3 / 1.097
=10.30

Cann Group's Receivables Turnover for the quarter that ended in Dec. 2025 is calculated as

Receivables Turnover (Q: Dec. 2025 )
=Revenue / Average Accounts Receivable
=Revenue (Q: Dec. 2025 ) / ((Accounts Receivable (Q: Jun. 2025 ) + Accounts Receivable (Q: Dec. 2025 )) / count )
=4.521 / ((0.587 + 0.868) / 2 )
=4.521 / 0.7275
=6.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Receivables Turnover →
What does a Receivables Turnover of 6.21 mean?
Cann Group (ASX:CAN) has a Receivables Turnover of 6.21 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Cann Group and its competitors. According to the industry distribution chart, Cann Group ranks #212 out of 944 companies in the Drug Manufacturers industry, placing it in the top 22.5%.
Is Cann Group's Receivables Turnover too high?
Cann Group's current Receivables Turnover is 6.21. The Drug Manufacturers industry median Receivables Turnover is 5.07. Cann Group's value of 6.21 is 22.5% above this industry median. Based on the distribution chart, Cann Group ranks #212 out of 944 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Cann Group's Receivables Turnover compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Cann Group ranks #212 out of 944 companies for Receivables Turnover. This places Cann Group in the top 23% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 5.07. Cann Group's value of 6.21 is 22.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Drug Manufacturers company?
The median Receivables Turnover among Drug Manufacturers companies is 5.07, based on 944 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cann Group's current Receivables Turnover of 6.21 is 22.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Cann Group and its competitors. For the Drug Manufacturers industry, the median Receivables Turnover is 5.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cann Group's current Receivables Turnover is 6.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cann Group stock overvalued right now?
Based on GuruFocus' analysis, Cann Group (ASX:CAN) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.02, compared to a current price of A$0.00 — trading 77.5% below its estimated fair value. The current Receivables Turnover is 6.21 and 22.5% above the Drug Manufacturers industry median of 5.07. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Cann Group (ASX:CAN), the current Receivables Turnover is 6.21 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cann Group Business Description

Other Exchanges CNGGF:USA
Address 262-276 Lorimer Street, Ground Floor, Port Melbourne, VIC, AUS, 3207
Cann Group Ltd is engaged in the cultivation of medicinal cannabis for both medicinal and research purposes under the licenses and permits issued to the company, the development and manufacture (via third-party arrangements) of finished product formulations. Geographically, the company operates in Europe and Australia. The company derives maximum revenue from Australia.